» Articles » PMID: 22824066

A Natural Vanishing Act: the Enzyme-catalyzed Degradation of Carbon Nanomaterials

Overview
Journal Acc Chem Res
Specialty Chemistry
Date 2012 Jul 25
PMID 22824066
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Over the past three decades, revolutionary research in nanotechnology by the scientific, medical, and engineering communities has yielded a treasure trove of discoveries with diverse applications that promise to benefit humanity. With their unique electronic and mechanical properties, carbon nanomaterials (CNMs) represent a prime example of the promise of nanotechnology with applications in areas that include electronics, fuel cells, composites, and nanomedicine. Because of toxicological issues associated with CNMs, however, their full commercial potential may not be achieved. The ex vitro, in vitro, and in vivo data presented in this Account provide fundamental insights into the biopersistence of CNMs, such as carbon nanotubes and graphene, and their oxidation/biodegradation processes as catalyzed by peroxidase enzymes. We also communicate our current understanding of the mechanism for the enzymatic oxidation and biodegradation. Finally, we outline potential future directions that could enhance our mechanistic understanding of the CNM oxidation and biodegradation and could yield benefits in terms of human health and environmental safety. The conclusions presented in this Account may catalyze a rational rethinking of CNM incorporation in diverse applications. For example, armed with an understanding of how and why CNMs undergo enzyme-catalyzed oxidation and biodegradation, researchers can tailor the structure of CNMs to either promote or inhibit these processes. In nanomedical applications such as drug delivery, the incorporation of carboxylate functional groups could facilitate biodegradation of the nanomaterial after delivery of the cargo. On the other hand, in the construction of aircraft, a CNM composite should be stable to oxidizing conditions in the environment. Therefore, pristine, inert CNMs would be ideal for this application. Finally, the incorporation of CNMs with defect sites in consumer goods could provide a facile mechanism that promotes the degradation of these materials once these products reach landfills.

Citing Articles

Myeloperoxidase enzyme-catalyzed breakdown of zero-dimension carbon quantum dots.

Singh P, Singh L Front Med Technol. 2024; 6:1493288.

PMID: 39669902 PMC: 11634592. DOI: 10.3389/fmedt.2024.1493288.


Therapeutic applications of carbon nanomaterials in renal cancer.

Priyam J, Saxena U Biotechnol Lett. 2023; 45(11-12):1395-1416.

PMID: 37864745 DOI: 10.1007/s10529-023-03429-0.


Lung Persistence, Biodegradation, and Elimination of Graphene-Based Materials are Predominantly Size-Dependent and Mediated by Alveolar Phagocytes.

Loret T, Visani de Luna L, Lucherelli M, Fordham A, Lozano N, Bianco A Small. 2023; 19(39):e2301201.

PMID: 37264768 PMC: 11475755. DOI: 10.1002/smll.202301201.


A Short Review on Nanostructured Carbon Containing Biopolymer Derived Composites for Tissue Engineering Applications.

Bartoli M, Piatti E, Tagliaferro A Polymers (Basel). 2023; 15(6).

PMID: 36987346 PMC: 10056897. DOI: 10.3390/polym15061567.


Does black phosphorus hold potential to overcome graphene oxide? A comparative review of their promising application for cancer therapy.

Ruiz A, Martin C, Reina G Nanoscale Adv. 2022; 3(14):4029-4036.

PMID: 36132840 PMC: 9418961. DOI: 10.1039/d1na00203a.


References
1.
Karousis N, Tagmatarchis N, Tasis D . Current progress on the chemical modification of carbon nanotubes. Chem Rev. 2010; 110(9):5366-97. DOI: 10.1021/cr100018g. View

2.
Nunes A, Bussy C, Gherardini L, Meneghetti M, Herrero M, Bianco A . In vivo degradation of functionalized carbon nanotubes after stereotactic administration in the brain cortex. Nanomedicine (Lond). 2012; 7(10):1485-94. DOI: 10.2217/nnm.12.33. View

3.
Vlasova I, Sokolov A, Chekanov A, Kostevich V, Vasilev V . [Myeloperoxidase-induced biodegradation of single-walled carbon nanotubes is mediated by hypochlorite]. Bioorg Khim. 2011; 37(4):510-21. DOI: 10.1134/s1068162011040157. View

4.
Shvedova A, Kapralov A, Feng W, Kisin E, Murray A, Mercer R . Impaired clearance and enhanced pulmonary inflammatory/fibrotic response to carbon nanotubes in myeloperoxidase-deficient mice. PLoS One. 2012; 7(3):e30923. PMC: 3316527. DOI: 10.1371/journal.pone.0030923. View

5.
Veitch N . Horseradish peroxidase: a modern view of a classic enzyme. Phytochemistry. 2004; 65(3):249-59. DOI: 10.1016/j.phytochem.2003.10.022. View